ArticleVeterinary research communications2026
Dietary watermelon (Citrullus lanatus) rind mitigates nickel- and copper-induced hepatic, metabolic, and nrf2/keap1 signaling disruptions in Nile tilapia (Oreochromis niloticus).
Article in Veterinary research communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Rising nickel (Ni) and copper (Cu) pollution in water bodies has the potential to alter fish physiology and undermine aquaculture sustainability. A valuable byproduct, the watermelon rind (Citrullus lanatus), has potent antioxidant properties. However, its hepatoprotective role against Ni + Cu co-exposure in Nile tilapia (Oreochromis niloticus) remains uninvestigated. Hence, this study assessed the efficacy of dietary C. lanatus rind powder (CLRP) in safeguarding against liver damage induced by Ni + Cu. Fish (37.30 ± 0.20 g) were assigned to four groups: control, CLRP (40 g/kg diet), Ni + Cu (3.60 and 3.35 mg/L), and CLRP + Ni+Cu for 45 days. Findings showed hepatic dysfunction, as evidenced by increased liver enzymes and reduced protein fractions concurrent with Ni and Cu exposure. In addition, disruption of the lipid profile (increased triglycerides and cholesterol) and elevation of bilirubin fractions were evident in the Ni + Cu group. Simultaneous exposure to Ni and Cu induced suppression of antioxidant enzyme activities (superoxide dismutase, catalase, and glutathione peroxidase), besides the elevation of malondialdehyde levels. Microscopic analysis of hepatic tissue showed hepatocyte necrosis and degeneration as well as dilation of the portal veins. Furthermore, the co-occurring exposure altered the antioxidant signaling pathway (nrf2/keap1). It also downregulated immune function genes (il10 and ctsb) and upregulated stress response genes (hsp70 and hsp90). Importantly, CLRP supplementation notably strengthens antioxidant capacity, supports lipid metabolism, and maintains liver architecture. Additionally, it reduces hepatocyte injury and transcriptional disruptions. Overall, CLRP (40 g/kg) shows promise in protecting Nile tilapia against Ni + Cu combined exposure, supporting its use as a feed additive in aquaculture.
Indexed as
Identifiers
42789041What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.